Jim Harding

Propel Bio Management, Llc

Assets Managed

$158.659M

Holdings

Last Quarter

2026 - Q1

Filed Date

14d ago

Growth Rate

35.47%(2Q avg: 26.36%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Propel Bio Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 38 positions.

Assets under management

The assets under management (AUM) of Propel Bio Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 158.659M in assets, with a quarterly growth rate of 35.47% and a 2-quarter average growth rate of 26.36%. The portfolio is managed by Jim Harding, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
PAGP Plains Gp Holdings Lp-cl A Recent Activity	19.03%	$30.18M 1.272M shares@ $23.72 avg price
ACHV Achieve Life Sciences Inc Recent Activity	7.17%	$11.369M 3.786M shares@ $3.01 avg price
PHAT Phathom Pharmaceuticals Inc Recent Activity Increased 13.55%	5.9%	$9.354M 841,272 shares@ $11.12 avg price	Increased 13.55%
DCTH Delcath Systems Inc Recent Activity Increased 123.42%	5.78%	$9.159M 979,698 shares@ $9.35 avg price	Increased 123.42%
CORT Corcept Therapeutics Inc Recent Activity New Position	3.8%	$6.022M 147,828 shares@ $40.74 avg price	New Position
ABEO Abeona Therapeutics Inc Recent Activity Increased 60.08%	3.79%	$6.008M 1.33M shares@ $4.52 avg price	Increased 60.08%
VOR Vor Biopharma Inc Recent Activity New Position	3.53%	$5.587M 314,543 shares@ $17.77 avg price	New Position
KYTX Kyverna Therapeutics Inc Recent Activity Decreased -3.33%	3.53%	$5.586M 644,421 shares@ $8.67 avg price	Decreased -3.33%
MIST Milestone Pharmaceuticals In Recent Activity	3.21%	$5.082M 4.118M shares@ $1.24 avg price
CLDX Celldex Therapeutics Inc Recent Activity Decreased -14.86%	2.61%	$4.135M 131,364 shares@ $31.48 avg price	Decreased -14.86%

1-10 of 38